Moestrup S K, Holtet T L, Etzerodt M, Thøgersen H C, Nykjaer A, Andreasen P A, Rasmussen H H, Sottrup-Jensen L, Gliemann J
Institute of Medical Biochemistry, University of Aarhus, Denmark.
J Biol Chem. 1993 Jun 25;268(18):13691-6.
A region containing sites for ligand binding was localized in the 4525-amino acid residue alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein (alpha 2MR/LRP) by ligand- and immunoblotting of proteinase and CNBr digests of the purified human placental protein. 125I-Labeled rat alpha 1-macroglobulin light chain, urokinase-plasminogen activator inhibitor type-1 complex, and alpha 2MR-associated protein all bound to a 75-kDa CNBr-generated fragment (68 kDa after deglycosylation). In addition to the three ligands, the fragment bound a novel monoclonal antibody reacting in the region defined by amino acid residues 1165-1246 as determined by binding to recombinant fragments of alpha 2MR/LRP. The positions of methionine residues in alpha 2MR/LRP suggested that the ligand-binding CNBr fragment contained three disulfide-linked peptides comprising the residues 776-1399. This origin was confirmed by partial amino acid sequencing of the electroblotted fragment and polypeptides generated by reduction of the fragment. The identified region represents 13.6% of the molecular mass (nonglycosylated) of alpha 2MR/LRP and contains one of three large clusters of complement-type repeats.
通过对纯化的人胎盘蛋白进行蛋白酶和溴化氰消化产物的配体结合及免疫印迹分析,在含有4525个氨基酸残基的α2-巨球蛋白受体/低密度脂蛋白受体相关蛋白(α2MR/LRP)中定位了一个配体结合位点区域。125I标记的大鼠α1-巨球蛋白轻链、尿激酶-纤溶酶原激活物抑制剂-1复合物以及α2MR相关蛋白均与一个75 kDa的溴化氰生成片段(去糖基化后为68 kDa)结合。除了这三种配体,该片段还结合了一种新型单克隆抗体,该抗体在由α2MR/LRP重组片段结合确定的氨基酸残基1165 - 1246所定义的区域内发生反应。α2MR/LRP中甲硫氨酸残基的位置表明,配体结合的溴化氰片段包含三个由二硫键连接的肽段,其氨基酸残基范围为776 - 1399。通过对电印迹片段和片段还原后产生的多肽进行部分氨基酸测序,证实了该片段的来源。所确定的区域占α2MR/LRP分子质量(非糖基化)的13.6%,并且包含三个补体样重复序列大簇之一。